Metastatic renal cell carcinoma: A guide to therapy based on current evidence
Metastatic renal cell carcinoma (RCC) was, until recently, considered a challenging disease to treat with few therapeutic options of limited benefit. The past few years have seen spectacular advances in the treatment of this disease based on understanding the molecular pathways behind tumor growth a...
Main Author: | Choueiri Toni |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2009-01-01
|
Series: | Urology Annals |
Subjects: | |
Online Access: | http://www.urologyannals.com/article.asp?issn=0974-7796;year=2009;volume=1;issue=1;spage=9;epage=14;aulast=Choueiri |
Similar Items
-
Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
by: Ravi K. Paluri, et al.
Published: (2019-11-01) -
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling
by: Robin K. Kelley, et al.
Published: (2021-09-01) -
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation
by: J Thompson Coon, et al.
Published: (2010-01-01) -
Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer
by: Dimitrios Zardavas, et al.
Published: (2011-01-01) -
Pazopanib in the treatment of advanced renal cell carcinoma
by: M. I. Volkova, et al.
Published: (2018-11-01)